{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T01:44:22Z","timestamp":1777340662806,"version":"3.51.4"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2005,4,4]],"date-time":"2005-04-04T00:00:00Z","timestamp":1112572800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"published-print":{"date-parts":[[2005,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Primary open angle glaucoma (POAG) is considered to be a neurodegenerative optic neuropathy, in which cell death occurs by apoptosis. <jats:italic>p21<\/jats:italic>, is an important protective component of the apoptotic pathway, regulating cellular arrest in the presence of DNA damage. An unstable or altered p21 protein could modify the cellular response to genomic injury and abolish the effect of <jats:italic>p21<\/jats:italic>. A previous study on a Chinese cohort suggested that the <jats:italic>p21<\/jats:italic> codon 31 polymorphism may alter the state of apoptosis in glaucomatous optic neuropathy, failing to protect the ganglion cells. The aim of this study was to test the hypothesis that a <jats:italic>p21<\/jats:italic> codon 31 polymorphism is associated with POAG on a Caucasian cohort.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>140 POAG patients and a control group of 73 healthy individuals were included in the study. All the subjects were of Caucasian origin. Genomic DNA was amplified by polymerase chain reaction, followed by enzymatic restriction fragment length polymorphism technique (PCR-RFLP). Patients and controls were genotyped for a single nucleotide polymorphism (C\/A transversion) in the third base of codon 31 of p21, which leads to a serine (Ser)\/arginine (Arg) substitution.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The distribution of the genotypes in the POAG patients showed 128 (91.4%) Ser homozygotes, 10 (7.1%) Ser\/Arg heterozygotes and 2 (1.5%) Arg homozygotes. In the control cohort, there were 61 (83.6%) Ser homozygotes and 12 (16.4%) Ser\/Arg heterozygotes. No Arg homozygotes were present amongst the control group. Both the allelic and genotypic frequencies of the Ser or Arg residues at codon 31 were not significantly different between POAG patients and controls (Fisher's exact test, P = 0.20 for alleles and P = 0.0561 for genotypes).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>This study suggests that the p21 codon 31 polymorphism does not contribute to the risk of POAG in the Caucasian population.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2415-5-5","type":"journal-article","created":{"date-parts":[[2005,4,5]],"date-time":"2005-04-05T06:13:42Z","timestamp":1112681622000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["A polymorphism at codon 31 of gene p21 is not associated with primary open angle glaucoma in Caucasians"],"prefix":"10.1186","volume":"5","author":[{"given":"Thomas","family":"Ressiniotis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip G","family":"Griffiths","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon M","family":"Keers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick F","family":"Chinnery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Birch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2005,4,4]]},"reference":[{"key":"38_CR1","first-page":"83","volume":"38","author":"HA Quigley","year":"1997","unstructured":"Quigley HA, Vitale S: Models of open-angle glaucoma prevalence and incidence in the United States. Invest Ophthalmol Vis Sci. 1997, 38: 83-91.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"38_CR2","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1016\/S0140-6736(99)04240-3","volume":"354","author":"AL Coleman","year":"1999","unstructured":"Coleman AL: Glaucoma. Lancet. 1999, 354: 1803-1810. 10.1016\/S0140-6736(99)04240-3.","journal-title":"Lancet"},{"key":"38_CR3","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/S0002-9394(14)70314-9","volume":"117","author":"PR Lichter","year":"1994","unstructured":"Lichter PR: Genetic clues to glaucoma's secrets. The L Edward Jackson Memorial Lecture. Part 2. Am J Ophthalmol. 1994, 117: 706-727.","journal-title":"Am J Ophthalmol"},{"key":"38_CR4","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1097\/00055735-200204000-00001","volume":"13","author":"D WuDunn","year":"2002","unstructured":"WuDunn D: Genetic basis of glaucoma. Curr Opin Ophthalmol. 2002, 13: 55-60. 10.1097\/00055735-200204000-00001.","journal-title":"Curr Opin Ophthalmol"},{"key":"38_CR5","doi-asserted-by":"publisher","first-page":"S151","DOI":"10.1016\/S0039-6257(99)00029-6","volume":"43 Suppl 1","author":"RW Nickells","year":"1999","unstructured":"Nickells RW: Apoptosis of retinal ganglion cells in glaucoma: an update of the molecular pathways involved in cell death. Surv Ophthalmol. 1999, 43 Suppl 1: S151-61. 10.1016\/S0039-6257(99)00029-6.","journal-title":"Surv Ophthalmol"},{"key":"38_CR6","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/S0092-8674(00)81871-1","volume":"88","author":"AJ Levine","year":"1997","unstructured":"Levine AJ: p53, the cellular gatekeeper for growth and division. Cell. 1997, 88: 323-331. 10.1016\/S0092-8674(00)81871-1.","journal-title":"Cell"},{"key":"38_CR7","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/j.1395-3907.2004.0180.x","volume":"82","author":"FJ Tsai","year":"2004","unstructured":"Tsai FJ, Lin HJ, Chen WC, Tsai CH, Tsai SW: A codon 31ser-arg polymorphism of the WAF-1\/CIP-1\/p21\/tumour suppressor gene in Chinese primary open-angle glaucoma. Acta Ophthalmol Scand. 2004, 82: 76-80. 10.1111\/j.1395-3907.2004.0180.x.","journal-title":"Acta Ophthalmol Scand"},{"key":"38_CR8","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1002\/(SICI)1096-9896(199710)183:2<134::AID-PATH960>3.0.CO;2-D","volume":"183","author":"LS Cox","year":"1997","unstructured":"Cox LS: Multiple pathways control cell growth and transformation: overlapping and independent activities of p53 and p21Cip1\/WAF1\/Sdi1. J Pathol. 1997, 183: 134-140. 10.1002\/(SICI)1096-9896(199710)183:2<134::AID-PATH960>3.0.CO;2-D.","journal-title":"J Pathol"},{"key":"38_CR9","first-page":"1169","volume":"54","author":"WS el-Deiry","year":"1994","unstructured":"el-Deiry WS, Harper JW, O'Connor PM, Velculescu VE, Canman CE, Jackman J, Pietenpol JA, Burrell M, Hill DE, Wang Y, et al: WAF1\/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res. 1994, 54: 1169-1174.","journal-title":"Cancer Res"},{"key":"38_CR10","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/(SICI)1098-2744(199608)16:4<221::AID-MC6>3.0.CO;2-I","volume":"16","author":"LA Terry","year":"1996","unstructured":"Terry LA, Boyd J, Alcorta D, Lyon T, Solomon G, Hannon G, Berchuck A, Beach D, Barrett JC: Mutational analysis of the p21\/WAF1\/CIP1\/SDI1 coding region in human tumor cell lines. Mol Carcinog. 1996, 16: 221-228. 10.1002\/(SICI)1098-2744(199608)16:4<221::AID-MC6>3.0.CO;2-I.","journal-title":"Mol Carcinog"},{"key":"38_CR11","first-page":"3021","volume":"9","author":"M Chedid","year":"1994","unstructured":"Chedid M, Michieli P, Lengel C, Huppi K, Givol D: A single nucleotide substitution at codon 31 (Ser\/Arg) defines a polymorphism in a highly conserved region of the p53-inducible gene WAF1\/CIP1. Oncogene. 1994, 9: 3021-3024.","journal-title":"Oncogene"},{"key":"38_CR12","first-page":"127","volume":"11","author":"C Keshava","year":"2002","unstructured":"Keshava C, Frye BL, Wolff MS, McCanlies EC, Weston A: Waf-1 (p21) and p53 polymorphisms in breast cancer. Cancer Epidemiol Biomarkers Prev. 2002, 11: 127-130.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"38_CR13","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S1078-1439(01)00152-1","volume":"7","author":"WC Chen","year":"2002","unstructured":"Chen WC, Wu HC, Hsu CD, Chen HY, Tsai FJ: p21 gene codon 31 polymorphism is associated with bladder cancer. Urol Oncol. 2002, 7: 63-66. 10.1016\/S1078-1439(01)00152-1.","journal-title":"Urol Oncol"},{"key":"38_CR14","first-page":"599","volume":"10","author":"YJ Li","year":"1995","unstructured":"Li YJ, Laurent-Puig P, Salmon RJ, Thomas G, Hamelin R: Polymorphisms and probable lack of mutation in the WAF1-CIP1 gene in colorectal cancer. Oncogene. 1995, 10: 599-601.","journal-title":"Oncogene"},{"key":"38_CR15","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1159\/000154344","volume":"46","author":"R Birgander","year":"1996","unstructured":"Birgander R, Sjalander A, Saha N, Spitsyn V, Beckman L, Beckman G: The codon 31 polymorphism of the p53-inducible gene p21 shows distinct differences between major ethnic groups. Hum Hered. 1996, 46: 148-154.","journal-title":"Hum Hered"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2415-5-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2415-5-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2415-5-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2415-5-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,31]],"date-time":"2021-08-31T21:52:21Z","timestamp":1630446741000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/1471-2415-5-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4,4]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["38"],"URL":"https:\/\/doi.org\/10.1186\/1471-2415-5-5","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,4,4]]},"assertion":[{"value":"18 January 2005","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2005","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2005","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"5"}}